490 related articles for article (PubMed ID: 1385448)
1. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan.
Hayashi K; Madri JA; Yurchenco PD
J Cell Biol; 1992 Nov; 119(4):945-59. PubMed ID: 1385448
[TBL] [Abstract][Full Text] [Related]
2. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin.
Gauer S; Schulze-Lohoff E; Schleicher E; Sterzel RB
Eur J Cell Biol; 1996 Jul; 70(3):233-42. PubMed ID: 8832207
[TBL] [Abstract][Full Text] [Related]
3. Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide.
Drake SL; Klein DJ; Mickelson DJ; Oegema TR; Furcht LT; McCarthy JB
J Cell Biol; 1992 Jun; 117(6):1331-41. PubMed ID: 1607392
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
[TBL] [Abstract][Full Text] [Related]
5. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
6. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of beta 1 integrin-mediated cell adhesion to a large heparan sulfate proteoglycan from basement membranes.
Battaglia C; Aumailley M; Mann K; Mayer U; Timpl R
Eur J Cell Biol; 1993 Jun; 61(1):92-9. PubMed ID: 7693469
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells.
Tanaka Y; Kimata K; Wake A; Mine S; Morimoto I; Yamakawa N; Habuchi H; Ashikari S; Yamamoto H; Sakurai K; Yoshida K; Suzuki S; Eto S
J Exp Med; 1996 Nov; 184(5):1987-97. PubMed ID: 8920885
[TBL] [Abstract][Full Text] [Related]
9. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture.
Rescan PY; Loréal O; Hassell JR; Yamada Y; Guillouzo A; Clément B
Am J Pathol; 1993 Jan; 142(1):199-208. PubMed ID: 7678718
[TBL] [Abstract][Full Text] [Related]
10. Interaction of skeletal muscle cells with collagen type IV is mediated by perlecan associated with the cell surface.
Villar MJ; Hassell JR; Brandan E
J Cell Biochem; 1999 Dec; 75(4):665-74. PubMed ID: 10572249
[TBL] [Abstract][Full Text] [Related]
11. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture.
Fujiwara Y; Kaji T
Toxicology; 1999 Apr; 133(2-3):159-69. PubMed ID: 10378482
[TBL] [Abstract][Full Text] [Related]
12. An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan.
Tashiro K; Monji A; Yoshida I; Hayashi Y; Matsuda K; Tashiro N; Mitsuyama Y
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):119-26. PubMed ID: 10229666
[TBL] [Abstract][Full Text] [Related]
13. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate.
Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U
J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923
[TBL] [Abstract][Full Text] [Related]
14. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.
Whitelock JM; Murdoch AD; Iozzo RV; Underwood PA
J Biol Chem; 1996 Apr; 271(17):10079-86. PubMed ID: 8626565
[TBL] [Abstract][Full Text] [Related]
15. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.
Whitelock JM; Graham LD; Melrose J; Murdoch AD; Iozzo RV; Underwood PA
Matrix Biol; 1999 Apr; 18(2):163-78. PubMed ID: 10372557
[TBL] [Abstract][Full Text] [Related]
16. The neural cell adhesion molecule (NCAM) heparin binding domain binds to cell surface heparan sulfate proteoglycans.
Kallapur SG; Akeson RA
J Neurosci Res; 1992 Dec; 33(4):538-48. PubMed ID: 1484387
[TBL] [Abstract][Full Text] [Related]
17. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction.
Peng HB; Ali AA; Daggett DF; Rauvala H; Hassell JR; Smalheiser NR
Cell Adhes Commun; 1998 Sep; 5(6):475-89. PubMed ID: 9791728
[TBL] [Abstract][Full Text] [Related]
18. Proteoglycans of basement membranes.
Timpl R
Experientia; 1993 May; 49(5):417-28. PubMed ID: 8500597
[TBL] [Abstract][Full Text] [Related]
19. The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin.
Heremans A; De Cock B; Cassiman JJ; Van den Berghe H; David G
J Biol Chem; 1990 May; 265(15):8716-24. PubMed ID: 2140362
[TBL] [Abstract][Full Text] [Related]
20. Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.
Jalkanen M; Rapraeger A; Bernfield M
J Cell Biol; 1988 Mar; 106(3):953-62. PubMed ID: 2964452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
